........some things to google and do some DD. Must be some good reasons why Fidelity is invested heavily in Insmed. Insmed has 87% of their shares owned by institutions. What have their analysts discovered in their due diligence?
When I googled the EMEA number, I found the following. Is this helpful?
3.3.2. - amikacin - Orphan - EMEA/H/C/003936
Insmed Limited; treatment of Pseudomonas aeruginosa lung infection/colonisation in cystic fibrosis patients, treatment of nontuberculous mycobacterial lung infection
Scope: Day 120 list of questions and revised timetable on similarity assessment
Action: For adoption
....this report was released today after-hours.....UP approximately 150,000 shares
Avg Daily Share Volume
Days To Cover
7/15/2015 4,579,967 313,615 14.603788
6/30/2015 4,430,273 503,843 8.792963
So, I am assuming you have used the same strategy with regards to your Insmed holdings?
.....to move the SP from $25.91 to $25.65 LOL My goodness, but some people are really going to hurt sometime. Sometimes I feel sorry for them.......then I get over it.
If you had a short position....wouldn't you be verrrrrry nervous? I know I would.
That would be a good question for Fidelity or T Rowe Price
In my opinion, I'm not sure there has been much upside to Alzheimer drugs. For those who are old enough, you probably have the July/August AARP Bulletin. If you are not old enough yet, you may want to try to get the recent copy. There is a good article in it about the benefit of music for Alzheimer's patients. I bring this up, not for any investment strategy or opinion, but if you know someone who has Alzheimer's or the beginning stages of Dementia, you may want explore to see if there might be some benefit to your current situation. Music is better than drugs.......in my humble opinion.
I seem to recall Terry mentioning back some time (almost two years, I think) about shorting HALO, but not buying it. I also don't remember him mentioning XOMA. I remember Biowatchdog giving a list of about 6 stocks he was in......XOMA was on the list.
I'm sorry, Check, but I don't understand the reason for having a name change. Currently, Insmed is a stand alone company......or am I missing something?